Prostacyclin analogues decrease platelet aggregation but have no effect on thrombin generation, fibrin clot structure, and fibrinolysis in pulmonary arterial hypertension: PAPAYA coagulation.

Carica Coagulants / pharmacology Epoprostenol / pharmacology Fibrin Fibrinolysis Humans Platelet Aggregation Prostaglandins I / pharmacology Pulmonary Arterial Hypertension Thrombin / pharmacology
Fibrin clot fibrinolysis platelet reactivity prostacyclin analogues pulmonary arterial hypertension thrombin generation

Journal

Platelets
ISSN: 1369-1635
Titre abrégé: Platelets
Pays: England
ID NLM: 9208117

Informations de publication

Date de publication:
03 Oct 2022
Historique:
pubmed: 15 3 2022
medline: 26 8 2022
entrez: 14 3 2022
Statut: ppublish

Résumé

Prostacyclin (PGI

Identifiants

DOI: 10.1080/09537104.2022.2042234 PMID: 35285383
pubmed: 35285383
doi: 10.1080/09537104.2022.2042234
doi:

Substances chimiques

Coagulants 0
Prostaglandins I 0
Fibrin 9001-31-4
Epoprostenol DCR9Z582X0
Thrombin EC 3.4.21.5

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1065-1074

Auteurs

Aleksander Siniarski (A)

Department of Coronary Artery Disease and Heart Failure, Institute of Cardiology, Jagiellonian University Medical College, John Paul II Hospital, Kraków, Poland.
ORCID: 0000-0002-7493-3626

Aleksandra Gąsecka (A)

1st Chair and Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.
ORCID: 0000-0001-5083-7587

Miłosz Starczyński (M)

1 Chair and Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.
ORCID: 0000-0002-3630-4044

Marta Banaszkiewicz (M)

Department of Pulmonary Circulation, Thromboembolic Diseases and Cardiology, Centre of Postgraduate Medical Education, European Health Centre Otwock, Poland.

Szymon Darocha (S)

Department of Pulmonary Circulation, Thromboembolic Diseases and Cardiology, Centre of Postgraduate Medical Education, European Health Centre Otwock, Poland.
ORCID: 0000-0001-8298-9243

Adam Torbicki (A)

Department of Pulmonary Circulation, Thromboembolic Diseases and Cardiology, Centre of Postgraduate Medical Education, European Health Centre Otwock, Poland.

Marcin Kurzyna (M)

Department of Pulmonary Circulation, Thromboembolic Diseases and Cardiology, Centre of Postgraduate Medical Education, European Health Centre Otwock, Poland.

Krzysztof J Filipiak (KJ)

Department of Clinical Sciences, Maria Sklodowska-Curie Medical Academy, Warsaw, Poland.
ORCID: 0000-0002-6563-0877

Jadwiga Nessler (J)

Department of Coronary Artery Disease and Heart Failure, Institute of Cardiology, Jagiellonian University Medical College, John Paul II Hospital, Kraków, Poland.
ORCID: 0000-0002-5076-5816

Grzegorz Gajos (G)

Department of Coronary Artery Disease and Heart Failure, Institute of Cardiology, Jagiellonian University Medical College, John Paul II Hospital, Kraków, Poland.
ORCID: 0000-0002-7361-3559

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Viridiplantae › Streptophyta › Embryophyta › Tracheobionta › Magnoliopsida › Caricaceae › Carica › Prostacyclin analogues decrease platelet...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Agents hématologiques › Coagulants › Prostacyclin analogues decrease platelet...
questionsmedicales.fr › Facteurs biologiques › Médiateurs de l'inflammation › Autacoïdes › Éicosanoïdes › Prostaglandines › Prostaglandines I › Prostacycline › Prostacyclin analogues decrease platelet...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines du sang › Fibrine › Prostacyclin analogues decrease platelet...
questionsmedicales.fr › Phénomènes physiologiques respiratoires et circulatoires › Phénomènes physiogiques du sang › Hémostase › Coagulation sanguine › Fibrinolyse › Prostacyclin analogues decrease platelet...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Prostacyclin analogues decrease platelet...
questionsmedicales.fr › Phénomènes physiologiques respiratoires et circulatoires › Phénomènes physiogiques du sang › Hémostase › Activation plaquettaire › Agrégation plaquettaire › Prostacyclin analogues decrease platelet...
questionsmedicales.fr › Facteurs biologiques › Médiateurs de l'inflammation › Autacoïdes › Éicosanoïdes › Prostaglandines › Prostaglandines I › Prostacyclin analogues decrease platelet...
questionsmedicales.fr › Maladies de l'appareil respiratoire › Maladies pulmonaires › Hypertension artérielle pulmonaire › Prostacyclin analogues decrease platelet...
questionsmedicales.fr › Facteurs biologiques › Facteurs de la coagulation sanguine › Thrombine › Prostacyclin analogues decrease platelet...